Literature DB >> 27055839

Validation of the King's Sarcoidosis Questionnaire (KSQ) in a Dutch sarcoidosis population.

Mirjam J G Van Manen1, Monique Wapenaar, Bert Strookappe, Marjolein Drent, Marjon Elfferich, Jolanda de Vries, Harry R Gosker, Surinder S Birring, Amit S Patel, Leon van den Toorn, Bernt van den Blink, Karin Boomars, Elske Hoitsma, Marlies S Wijsenbeek.   

Abstract

BACKGROUND: The King's Sarcoidosis Questionnaire (KSQ) is a brief questionnaire assessing health status using five modules (General Health Status, Lung, Eyes, Skin, Medication) in patients with sarcoidosis. The KSQ was only validated in one English sarcoidosis cohort.
OBJECTIVE: The aim of this study was to validate the KSQ in a Dutch sarcoidosis population.
METHODS: The KSQ was translated according to international guidelines and tested in interviews with patients. Consecutive outpatients completed multiple questionnaires twice, two weeks apart. Construct validity, internal consistency and repeatability were determined.
RESULTS: Of the 98 patients included 85 had lung, 22 skin and 24 eye disease. There was good construct validity of the KSQ General Health Status module against the World Health Organization Quality of Life-BREF questionnaire. The Medication module correlated weak to moderate with most questionnaires. The correlations with organ-specific questionnaires varied from strong for Eyes (r=0.75), Skin (r=-0.62) to moderate for Lung (r=-0.45 with MRC breathlessness scale). Internal consistency was good for all KSQ modules (Cronbach's α 0.72-0.93). Intraclass correlation coefficients (0.70-0.90) and Bland-Altman plots showed good repeatability of the KSQ.
CONCLUSION: The Dutch KSQ is the first translation of the English KSQ, validated in a Dutch sarcoidosis population.

Entities:  

Keywords:  Sarcoidosis, Health status, Questionnaire, Quality of Life

Mesh:

Year:  2016        PMID: 27055839

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  8 in total

1.  Physical Activity and Fatigue in Patients with Sarcoidosis.

Authors:  Thomas Bahmer; Henrik Watz; Maria Develaska; Benjamin Waschki; Klaus F Rabe; Helgo Magnussen; Detlef Kirsten; Anne-Marie Kirsten
Journal:  Respiration       Date:  2017-11-09       Impact factor: 3.580

2.  Association of Medication Adherence and Clinical Outcomes in Sarcoidosis.

Authors:  Michelle Sharp; Taylor Brown; Edward S Chen; Cynthia S Rand; David R Moller; Michelle N Eakin
Journal:  Chest       Date:  2020-02-04       Impact factor: 9.410

3.  First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative.

Authors:  Nynke A Kampstra; Jan C Grutters; Frouke T van Beek; Daniel A Culver; Robert P Baughman; Elisabetta A Renzoni; Wim Wuyts; Vaslis Kouranos; Marlies S Wijsenbeek; Douwe H Biesma; Philip J van der Wees; Paul B van der Nat
Journal:  BMJ Open Respir Res       Date:  2019-02-18

4.  Scalp hair cortisol and testosterone levels in patients with sarcoidosis.

Authors:  M J G van Manen; V L Wester; E F C van Rossum; L M van den Toorn; K Y Dorst; Y B de Rijke; M S Wijsenbeek
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

5.  Determination of the smallest detectable change (SDC) and the minimal important difference (MID) for the Small Fiber Neuropathy Screening List (SFNSL) in sarcoidosis.

Authors:  Mareye Voortman; Emmylou Beekman; Marjolein Drent; Elske Hoitsma; Jolanda De Vries
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

6.  How Do We Define a Meaningful Change in Quality of Life for Patients with Sarcoidosis?

Authors:  Kerri I Aronson; Jeffrey J Swigris
Journal:  Ann Am Thorac Soc       Date:  2021-03

7.  FeV1 and BMI influence King's Sarcoidosis Questionnaire score in sarcoidosis patients.

Authors:  Björn Christian Frye; Laura Potasso; Erik Farin-Glattacker; Surrinder Birring; Joachim Müller-Quernheim; Jonas Christian Schupp
Journal:  BMC Pulm Med       Date:  2021-12-03       Impact factor: 3.317

8.  Psychological burden associated with worse clinical outcomes in sarcoidosis.

Authors:  Michelle Sharp; Taylor Brown; Edward Chen; Cynthia S Rand; David R Moller; Michelle N Eakin
Journal:  BMJ Open Respir Res       Date:  2019-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.